Product Details for NDA 019614
VERELAN (VERAPAMIL HYDROCHLORIDE)
120MG
Marketing Status: Prescription
180MG
Marketing Status: Prescription
240MG
Marketing Status: Prescription
360MG
Marketing Status: Prescription
120MG
Marketing Status: Prescription
Active Ingredient: VERAPAMIL HYDROCHLORIDE
Proprietary Name: VERELAN
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 120MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N019614
Product Number: 001
Approval Date: May 29, 1990
Applicant Holder Full Name: AZURITY PHARMACEUTICALS INC
Marketing Status: Prescription
Patent and Exclusivity Information
VERELAN (VERAPAMIL HYDROCHLORIDE)
Proprietary Name: VERELAN
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 120MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N019614
Product Number: 001
Approval Date: May 29, 1990
Applicant Holder Full Name: AZURITY PHARMACEUTICALS INC
Marketing Status: Prescription
Patent and Exclusivity Information
180MG
Marketing Status: Prescription
Active Ingredient: VERAPAMIL HYDROCHLORIDE
Proprietary Name: VERELAN
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 180MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N019614
Product Number: 003
Approval Date: Jan 9, 1992
Applicant Holder Full Name: AZURITY PHARMACEUTICALS INC
Marketing Status: Prescription
Patent and Exclusivity Information
VERELAN (VERAPAMIL HYDROCHLORIDE)
Proprietary Name: VERELAN
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 180MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N019614
Product Number: 003
Approval Date: Jan 9, 1992
Applicant Holder Full Name: AZURITY PHARMACEUTICALS INC
Marketing Status: Prescription
Patent and Exclusivity Information
240MG
Marketing Status: Prescription
Active Ingredient: VERAPAMIL HYDROCHLORIDE
Proprietary Name: VERELAN
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 240MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N019614
Product Number: 002
Approval Date: May 29, 1990
Applicant Holder Full Name: AZURITY PHARMACEUTICALS INC
Marketing Status: Prescription
Patent and Exclusivity Information
VERELAN (VERAPAMIL HYDROCHLORIDE)
Proprietary Name: VERELAN
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 240MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N019614
Product Number: 002
Approval Date: May 29, 1990
Applicant Holder Full Name: AZURITY PHARMACEUTICALS INC
Marketing Status: Prescription
Patent and Exclusivity Information
360MG
Marketing Status: Prescription
Active Ingredient: VERAPAMIL HYDROCHLORIDE
Proprietary Name: VERELAN
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 360MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N019614
Product Number: 004
Approval Date: May 10, 1996
Applicant Holder Full Name: AZURITY PHARMACEUTICALS INC
Marketing Status: Prescription
Patent and Exclusivity Information
Proprietary Name: VERELAN
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 360MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N019614
Product Number: 004
Approval Date: May 10, 1996
Applicant Holder Full Name: AZURITY PHARMACEUTICALS INC
Marketing Status: Prescription
Patent and Exclusivity Information